Pharming Group N.V. Revenue From Contracts With Customers
Pharming Group N.V. (PHAR) reported Revenue From Contracts With Customers of $376.13 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-02.
Financial Statements › Income Statement › Other Income
ifrs-full:RevenueFromContractsWithCustomers · last filed 2026-04-02
EUR
| Period end | Revenue From Contracts With Customers 12 month |
|---|---|
| 2020-12-31 | 185.69M EUR 20-F · filed 2021-04-07 |
| 2019-12-31 | 169.02M EUR 20-F · filed 2021-04-07 |
| 2018-12-31 | 135.13M EUR 20-F · filed 2021-04-07 |
USD
| Period end | Revenue From Contracts With Customers 12 month |
|---|---|
| 2025-12-31 | $376.13M 20-F · filed 2026-04-02 |
| 2024-12-31 | $297.20M 20-F · filed 2026-04-02 |
| 2023-12-31 | $245.32M 20-F · filed 2026-04-02 |
| 2022-12-31 | $205.62M 20-F · filed 2025-04-03 |
| 2021-12-31 | $198.87M 20-F · filed 2024-04-04 |
| 2020-12-31 | $212.17M 20-F · filed 2023-04-05 |
| 2019-12-31 | $189.39M 20-F · filed 2022-04-06 |